BJA Advance Access originally published online on April 30, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
British Journal of Anaesthesia, 2004, Vol. 93, No. 1 105-113
© 2004 The Board of Management and Trustees of the British Journal of Anaesthesia
Physiology of the endothelium
Academic Unit of Anaesthesia & Intensive Care, School of Medicine, University of Aberdeen AB25 2ZD, Scotland UK
*Corresponding author. E-mail: n.r.webster{at}abdn.ac.uk
Abstract
In the past, the endothelium was considered to be inert, described as a ‘layer of nucleated cellophane’, with only non-reactive barrier properties, such as presentation of a non-thrombogenic surface for blood flow and guarding against pro-inflammatory insults. However, it is now becoming clear that endothelial cells actively and reactively participate in haemostasis and immune and inflammatory reactions. They regulate vascular tone via production of nitric oxide, endothelin and prostaglandins and are involved in the manifestations of atherogenesis, autoimmune diseases and infectious processes. They produce and react to various cytokines and adhesion molecules and it is now clear that they can mount anti- and pro-inflammatory and protective responses depending on environmental conditions and are key immunoreactive cells. Endothelial dysfunction or activation also contributes to a variety of disease states.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Sennoun, C. Baron-Menguy, M. Burban, T. Lecompte, R. Andriantsitohaina, D. Henrion, A. Mercat, P. Asfar, B. Levy, and F. Meziani Recombinant human activated protein C improves endotoxemia-induced endothelial dysfunction: a blood-free model in isolated mouse arteries Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H277 - H282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Turner and J. J. Lysiak Oxidative Stress: A Common Factor in Testicular Dysfunction J Androl, September 1, 2008; 29(5): 488 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Y. Chiang, D. C. Sheppard, F. N. Gravelat, T. F. Patterson, and S. G. Filler Aspergillus fumigatus Stimulates Leukocyte Adhesion Molecules and Cytokine Production by Endothelial Cells In Vitro and during Invasive Pulmonary Disease Infect. Immun., August 1, 2008; 76(8): 3429 - 3438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Talmor, E. Golan, S. Benchetrit, J. Bernheim, O. Klein, J. Green, and G. Rashid Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1059 - F1064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Prozialeck, J. R. Edwards, D. W. Nebert, J. M. Woods, A. Barchowsky, and W. D. Atchison The Vascular System as a Target of Metal Toxicity Toxicol. Sci., April 1, 2008; 102(2): 207 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Furst, T. Schroeder, H. M. Eilken, M. F. Bubik, A. K. Kiemer, S. Zahler, and A. M. Vollmar MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium FASEB J, January 1, 2007; 21(1): 74 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Alfranca, M. A. Iniguez, M. Fresno, and J. M. Redondo Prostanoid signal transduction and gene expression in the endothelium: Role in cardiovascular diseases Cardiovasc Res, June 1, 2006; 70(3): 446 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Williams, A. D. Hull, and W. J. Pearce Maturational modulation of endothelium-dependent vasodilatation in ovine cerebral arteries Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R149 - R157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.J. Howell, J.W. Sear, and J.D. Young Editorial: Cardiovascular medicine and Moore's Law Br. J. Anaesth., July 1, 2004; 93(1): 1 - 2. [Full Text] [PDF]
|
|